终末期肝病合并感染诊治专家共识

被引：38

作者：

陈韬

宁琴

机构：

[1] 中华医学会感染病学分会

来源：

临床肝胆病杂志 | 2018年 / 34卷 / 09期

关键词：

终末期肝病; 感染; 诊断; 治疗; 共识;

D O I：

暂无

中图分类号：

R575 [肝及胆疾病];

学科分类号：

100201 [内科学];

摘要：

终末期肝病(ESLD)发生发展中,感染可以诱发或加重ESLD肝功能失代偿的发生,亦是ESLD发展过程中最易出现的并发症之一。ESLD合并感染的规范诊疗需求迫切,国内外尚无针对ESLD合并感染性疾病的诊治指南、行业标准或专家共识,本共识旨在指导并提高临床医务工作者对ESLD合并感染疾病的综合诊治能力。

引用

收藏

页码：1862 / 1872

页数：11

相关论文

共 82 条

[1]

Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections [J].

Nelson, Avery N. ;

Justo, Julie Ann ;

Bookstaver, P. Brandon ;

Kohn, Joseph ;

Albrecht, Helmut ;

Al-Hasan, Majdi N. .

INFECTION, 2017, 45 (05) :613-620

[2]

Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice.[J].Xue Sun;Xingping Duan;Changyuan Wang;Zhihao Liu;Pengyuan Sun;Xiaokui Huo;Xiaodong Ma;Huijun Sun;Kexin Liu;Qiang Meng.European Journal of Pharmacology.2017,

[3]

Blood Microbiota as a Potential Noninvasive Diagnostic Biomarker for Liver Fibrosis in Severely Obese Patients: Choose Carefully [J].

Ling, Zongxin ;

Liu, Xia ;

Cheng, Yiwen ;

Shao, Li ;

Jiang, Haiyin ;

Li, Lanjuan .

HEPATOLOGY, 2017, 65 (05) :1775-1776

[4]

High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China [J].

Quan, Jingjing ;

Zhao, Dongdong ;

Liu, Lilin ;

Chen, Yan ;

Zhou, Jiancang ;

Jiang, Yan ;

Du, Xiaoxing ;

Zhou, Zhihui ;

Akova, Murat ;

Yu, Yunsong .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) :273-280

[5]

Preemptive therapy of spontaneous fungal peritonitis [J].

Fiore, Marco ;

Andreana, Lorenzo ;

Leone, Sebastiano .

HEPATOLOGY, 2016, 64 (03) :997-998

[6]

The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations [J].

Pericleous, Marinos ;

Sarnowski, Alexander ;

Moore, Alice ;

Fijten, Rik ;

Zaman, Murtaza .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) :E10-E18

[7]

Variations of pharmacokinetics of drugs in patients with cirrhosis [J].

Pena, M. A. ;

Horga, J. F. ;

Zapater, P. .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) :441-458

[8]

AASLD guidelines for treatment of chronic hepatitis B [J].

Terrault, Norah A. ;

Bzowej, Natalie H. ;

Chang, Kyong-Mi ;

Hwang, Jessica P. ;

Jonas, Maureen M. ;

Murad, M. Hassan .

HEPATOLOGY, 2016, 63 (01) :261-283

[9]

Management of uninfected and infected ascites in cirrhosis.[J].Elsa Solà;Cristina Solé;Pere Ginès.Liver Int.2016,

[10]

Left-sided infective endocarditis in patients with liver cirrhosis [J].

Ruiz-Morales, J. ;

Ivanova-Georgieva, R. ;

Fernandez-Hidalgo, N. ;

Garcia-Cabrera, E. ;

Miro, Jose M. ;

Munoz, P. ;

Almirante, B. ;

Plata-Ciezar, A. ;

Gonzalez-Ramallo, V. ;

Galvez-Acebal, J. ;

Farinas, M. C. ;

Bravo-Ferrer, J. M. ;

Goenaga-Sanchez, M. A. ;

Hidalgo-Tenorio, C. ;

Goikoetxea-Agirre, J. ;

de Alarcon-Gonzalez, A. .

JOURNAL OF INFECTION, 2015, 71 (06) :627-641

← 1 2 3 4 5 6 7 8 9 →